Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Some...

FDA Recall #D-0358-2025 — Class II — March 21, 2025

Recall #D-0358-2025 Date: March 21, 2025 Classification: Class II Status: Ongoing

Product Description

Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-383-10

Reason for Recall

Lack of Assurance of Sterility: Media fill with bacterial contamination

Recalling Firm

Somerset Therapeutics Private Limited — Bengaluru, N/A

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

240 vials

Distribution

U.S. Nationwide

Code Information

A240482D, exp. date 08/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated